Brief: Ajanta Pharma - Signs In-Licensing Agreement With Biocon For Semaglutide
Dec 23 (Reuters) - Ajanta Pharma Ltd AJPH.NS: SIGNS IN-LICENSING AGREEMENT WITH BIOCON FOR SEMAGLUTIDE BIOCON TO SUPPLY SEMAGLUTIDE TO AJANTA FOR 26 COUNTRIES Source text: ID:nBSE7TL3HS Further company coverage: AJPH.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility